This is a procurement-oriented overview for distributors, hospitals, and clinics evaluating coronary artery disease & cardiac interventions devices. The specific combination of wires, balloons, atherectomy, and stents is determined by the interventional cardiologist based on lesion complexity, calcification, and overall clinical picture. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Coronary Artery Disease and Percutaneous Coronary Intervention
Percutaneous coronary intervention (PCI) is a catheter-based approach that reaches the coronary arteries through a small arterial access point, typically the radial or femoral artery. Coronary artery disease develops when atherosclerotic plaque accumulates within the arteries that supply the heart muscle, gradually narrowing the lumen and limiting blood flow. Contemporary practice relies heavily on drug-eluting stents, which release an antiproliferative agent to limit the tissue overgrowth that can cause restenosis.
Regulatory Status and Manufacturing
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Portfolio and Sizing
Within this category, INVAMED lists devices such as ATLAS Drug Eluting Coronary Stent System Cobalt Chromium, Atlas Coronary Stent System Cobalt Chromium, Atlas Coronary Stent System Stainless Steel, Extender Drug Eluting PTCA Balloon Catheter, Inwire PTCA Guidewire, TemREN Rotablator, AngioTEN Vascular Closure System. Size ranges, materials, and configurations are detailed in product documentation and the applicable IFU.
Key Considerations
- Dual antiplatelet therapy duration is individualized to the clinical presentation and the patient's bleeding risk.
- Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes.
- All INVAMED coronary devices are intended for use by trained interventional cardiologists under fluoroscopic guidance and per the IFU.
Frequently Asked Questions
What is the INVAMED drug-eluting stent called?
INVAMED's drug-eluting coronary stent is the ATLAS Drug Eluting Coronary Stent System, built on a cobalt-chromium L605 platform with a sirolimus coating.
What is the reported restenosis performance of the ATLAS DES?
INVAMED reports clinical data showing target lesion revascularization rates below 5% at 12 months; this reflects studied performance and is not an individual guarantee.
About INVAMED
INVAMED states it maintains a growing portfolio of international patents across its device range. INVAMED operates a dedicated R&D center (INVAcenter) focused on minimally invasive device development.
Clinical and Technical Context
INVAMED's Inwire PTCA Guidewire is offered for coronary wiring within the interventional line, alongside CTO and workhorse options. According to INVAMED, clinical data for the ATLAS DES show target lesion revascularization rates below 5% at 12 months, a figure that reflects studied performance rather than an individual guarantee. The need for extension support is judged case by case, since it depends on vessel geometry and the devices being delivered. The cobalt-chromium alloy underneath is intended to allow thin struts while preserving radial support, as described in the product documentation. INVAMED's ATLAS system elutes sirolimus at 1 microgram per square millimeter with a sustained controlled-release profile designed to cover the early healing window. INVAMED's ATLAS Drug Eluting Coronary Stent System uses a cobalt-chromium L605 platform with 60 micrometer struts and a sirolimus coating dosed at 1 microgram per square millimeter with sustained controlled release. During PCI a lesion is usually crossed with a guidewire, prepared with a balloon, and in most cases scaffolded with a stent that holds the vessel open. Selection among platforms is made by the operator according to vessel size, lesion characteristics, and deliverability requirements.
Related on INVAMED
- Coronary Artery Disease & Cardiac Interventions — product category
- What should be avoided after stent placement?
- Atlas Coronary Stent System Cobalt Chromium — Technical Overview
- Drug-Eluting Stent (DES) Technology: Technology, Uses and Considerations
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.